Loading the comparison…
Loading the comparison…
Any covered state and procedure, side by side
| Bone graft & orthobiologics · California | Bone graft & orthobiologics · Arizona | |
|---|---|---|
| Surgeons, 2024 | 57 | 19 |
| Medicare fee-for-service cases | 2,787 | 661 |
| Growth since 2019 (Medicare FFS) | −2.3%/yr | −4.1%/yr |
| Forecast cases (Medicare FFS) | 3,030 in 2030 | 740 in 2030 |
| Forecast growth | +1.4%/yr to 2030 | +1.8%/yr to 2030 |
| Per 1,000 Medicare beneficiaries | 0.8 | 0.9 |
| Medicare Advantage share | 56% | 54% |
| Out of hospital | 2% (+2 pts since 2019) | 2% (+1 pts since 2019) |
| Cases per surgeon | 49 | 35 |
| Top 10 surgeons' share | 44% | 78% |
| Surgeons growing | 6 | 2 |
| New since the base year | 6 | 3 |
| Likely to stop billing it | 14 by 2026 | 7 by 2026 |
| Forecast miss, 1 year (procedure) | 12% | 12% |
| Company payments per surgeon | $10K | $6,571 |
The counts above are the surgeons MedaRep names: who is growing, who is new, who is likely to stop and which companies engage them.